Results 221 to 230 of about 2,503,709 (341)
Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation [PDF]
Khashayar Esfahani +11 more
openalex +1 more source
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong +13 more
wiley +1 more source
Transplant renal vein thrombosis and stenosis were rescued by interventional radiology [PDF]
Naoki Uchida +9 more
openalex +1 more source
Background Using hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg +42 more
wiley +1 more source
Quadruple-drug induction therapy in highly sensitized patients [PDF]
Abendroth, D. +3 more
core +1 more source
Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
Wei-Hsuan Li +11 more
semanticscholar +1 more source
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean +4 more
wiley +1 more source
Intrarenal parapelvic cysts presenting as allograft dysfunction 10 years post-renal transplantation: a case report. [PDF]
Chae HH, Ser T, Harriman D, Nguan C.
europepmc +1 more source
Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation
J. Zuber +15 more
semanticscholar +1 more source

